The flavonoid beverage Haelan 951 induces growth arrest and apoptosis in pancreatic carcinoma cell lines in vitro

BMC Complementary and Alternative Medicine

Volumn 15, Issue 1, 2015, Pages

  Rothe, Juliane ^a   Wakileh, Michael ^a   Dreißiger, Katrin ^a   Weber, Heike ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALPASTATIN; CASPASE; FLAVONOID; FLUDROXYCORTIDE; ISOFLAVONE; LACTATE DEHYDROGENASE; LIPOCORTIN 5; ACRYLIC ACID DERIVATIVE; PD 150606;

APOPTOSIS; ARTICLE; CALCIUM BINDING; CANCER CELL LINE; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CELLS BY BODY ANATOMY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; FIBROBLAST; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREAS CANCER; PROTEIN FOLDING; RANK SUM TEST; STUDENT T TEST; WST-1 ASSAY; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; PANCREAS TUMOR; RAT; TUMOR CELL LINE;

ACRYLATES; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FLAVONOIDS; HUMANS; PANCREATIC NEOPLASMS; RATS;

EID: 84938747126     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0734-0     Document Type: Article

References (46)

1. Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford). 2008;10:58-62.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
3. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 2002;42:25-54.
4. Li M, Yu X, Guo H, Sun L, Wang A, Liu Q, et al. Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells. Tumour Biol. 2014;35:2461-71.
5. Saif MW. Is there a role for herbal medicine in the treatment of pancreatic cancer? JOP. 2008;10:403-7.
6. Zhang L, Wu C, Zhang Y, Liu F, Zhao M, Bouvet M, et al. Efficacy comparison of traditional Chinese medicine LQ versus gemcitabine in a mouse model of pancreatic cancer. J Cell Biochem. 2013;114:2131-7.
7. Kim SO, Kim MR. [6]-Gingerol prevents disassembly of cell junctions and activities of MMPs in invasive human pancreas cancer cells through ERK/NF- κ B/Snail signal transduction pathway. Evid Based Complement Alternat Med. 2013 (2013), Article ID 761852, 9 p. http://dx.doi.org/10.1155/2013/761852 .
8. Singh RP, Agarwal R. Natural flavonoids targeting deregulated cell cycle progression in cancer cells. Curr Drug Targets. 2006;7:345-54.
9. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther. 2001;90:157-77.
10. Weng CJ, Yen GC. Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev. 2012;31:323-51.
11. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M, et al. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. Nutr. 2000;130:1695-9.
12. Choi EJ, Kim T, Lee MS. Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells. Life Sci. 2007;80:1403-8.
13. Xiao JX, Huang GQ, Geng X, Qiu HW. Soy-derived isoflavones inhibit HeLa cell growth by inducing apoptosis. Plant Foods Hum Nutr. 2011;66:122-8.
14. Dong X, Xu W, Sikes RA, Wu C. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone. Food Chem. 2013;141:1923-33.
15. Hsu A, Bray TM, Helferich WG, Doerge DR, Ho E. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Exp Biol Med. 2010;235:90-7.
16. Klein A, He X, Roche M, Mallett A, Duska L, Supko JG, et al. Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy. Gynecol Oncol. 2006;100:205-9.
17. Leloup L, Wells A. Calpains as potential anti-cancer targets. Expert Opin Ther Targets. 2011;15:309-23.
18. Jánossy J, Ubezio P, Apáti A, Magócsi M, Tompa P, Friedrich P. Calpain as a multi-site regulator of cell cycle. Biochem Pharmacol. 2004;67:1513-21.
19. Nair V, Fams MS. Soy and cancer survivors: Dietary supplementation with fermented soy nutraceutical, Haelan 951 in patients who survived terminal cancers. In: Townsend letter for doctors & patients. 2004. p. 48-56.
20. Wang X, Clubbs EA, Bomser JA. Genistein modulates prostate epithelial cell proliferation via estrogen- and extracellular signal-regulated kinase-dependent pathways. J Nutr Biochem. 2006;17:204-10.
21. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998;58:3833-38.
22. Murata M, Midorikawa K, Koh M, Umezawa K, Kawanishi S. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs. Biochemistry. 2004;43:2569-77.
23. Wang C, Kurzer MS. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer. 1997;28:236-47.
24. Hollande E, Fanjul M, Houti N, Faye JC, Courriere P. Expression of estrogen receptors during growth of human pancreatic adenocarcinoma cells (Capan-1)-relationship with differentiation. In Vitro Cell Dev Biol Anim. 1998;34:593-9.
25. Haczynski J, Tarkowski R, Jarzabek K, Slomczynska M, Wolczynski S, Magoffin DA, et al. Human cultured skin fibroblasts express estrogen receptor alpha and beta. Int J Mol Med. 2002;10:149-53.
26. Choi EJ, Lee BH. Evidence for genistein mediated cytotoxicity and apoptosis in rat brain. Life Sci. 2004;75:499-509.
27. Jin Y, Wu H, Cohen EM, Wei J, Jin H, Prentice H, et al. Genistein and daidzein induce neurotoxicity at high concentrations in primary rat neuronal cultures. J Biomed Sci. 2007;14:275-84.
28. Büchler P, Gukovskaya AS, Mouria M, Büchler MC, Büchler MW, Friess H, et al. Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid. Pancreas. 2003;26:264-73.
29. Choi EJ, Kim GH. The antioxidant activity of daidzein metabolites, O'desmethylangolensin and equol, in HepG2 cells. Mol Med Rep. 2014;9:328-32.
30. McCabe Jr MJ, Orrenius S. Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II. Biochem Biophys Res Commun. 1993;194:944-50.
31. Ye R, Bodero A, Zhou BB, Khanna KK, Lavin MF, Lees-Miller SP. The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner. J Biol Chem. 2001;276:4828-33.
32. Vousden KH. Outcomes of p53 activation-spoilt for choice. J Cell Sci. 2006;119:5015-20.
33. Polkowski K, Mazurek AP. Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm. 2000;57:135-55.
34. Yakovlev AG, Di Giovanni S, Wang G, Liu W, Stoica B, Faden AI. BOK and NOXA are essential mediators of p53-dependent apoptosis. J Biol Chem. 2004;279:28367-74.
35. Gonen H, Shkedy D, Barnoy S, Kosower NS, Ciechanover A. On the involvement of calpains in the degradation of the tumor suppressor protein p53. FEBS Lett. 1997;406:17-22.
36. Guan N, Korukonda R, Hurh E, Schmittgen TD, Donkor IO, Dalton JT. Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines. Int J Oncol. 2006;29:655-63.
37. Delmas C, Aragou N, Poussard S, Cottin P, Darbon JM, Manenti S. MAP kinase-dependent degradation of p27Kip1 by calpains in choroidal melanoma cells. Requirement of p27Kip1 nuclear export. J Biol Chem. 2003;278:12443-51.
38. Zhu W, Murtha PE, Young CY. Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells. Biochem Biophys Res Commun. 1995;214:1130-37.
39. Atencio IA, Ramachandra M, Shabram P, Demers GW. Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ. 2000;11:247-53.
40. Łopatniuk P, Witkowski JM. Conventional calpains and programmed cell death. Acta Biochim Pol. 2011;58:287-96.
41. Chua BT, Guo K, Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem. 2000;275:5131-5.
42. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of S100 proteins. Curr Mol Med. 2013;13:24-57.
43. Chen H, Xu C, Jin Q, Liu Z. S100 protein family in human cancer. Am J Cancer Res. 2014;4:89-115.
44. Tabata T, Tsukamoto N, Fooladi AA, Yamanaka S, Furukawa T, Ishida M, et al. RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells. Biochem Biophys Res Commun. 2009;390:475-80.
45. Che P, Yang Y, Han X, Hu M, Sellers JC, Londono-Joshi AI, et al. S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase. Sci Rep. 2015;5:8453.
46. Tamaki Y, Iwanaga Y, Niizuma S, Kawashima T, Kato T, Inuzuka Y, et al. Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. J Mol Cell Cardiol. 2013;57:72-81.